AsOf

Recorded or changed on this day 2026-11-08

2,401–2,450 of 46,541 claims, by entity. Everything on 2026-11-08 →

superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 751,217,078 shares
Amgen shares outstanding: 751,217,078 shares, claim clm_DACE114B6A42 · ended · superseded by clm_9F5464384718 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 19,902,000,000 United States dollar
Amgen total equity: 19,902,000,000 United States dollar, claim clm_DB1DDF8CC003 · ended · superseded by clm_4CC7E97EBEA6 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 11,415,000,000 United States dollar
Amgen cash and equivalents: 11,415,000,000 United States dollar, claim clm_DB87B36EEE9A · ended · superseded by clm_FAAD62580296 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 924,091,356 shares
Amgen shares outstanding: 924,091,356 shares, claim clm_DB95FD72A669 · ended · superseded by clm_D1EFB8E701BD · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 22,667,000,000 United States dollar
Amgen total equity: 22,667,000,000 United States dollar, claim clm_DBA659E53482 · ended · superseded by clm_F7BBC59E66C1 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 3,514,000,000 United States dollar
Amgen quarterly operating income: 3,514,000,000 United States dollar, claim clm_DBECC41209EA · ended · superseded by clm_B7EB0BB6DBEB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 6,903,000,000 United States dollar
Amgen quarterly revenue: 6,903,000,000 United States dollar, claim clm_DC8081A3AB65 · ended · superseded by clm_458A0C01DCF8 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 5,348,000,000 United States dollar
Amgen total equity: 5,348,000,000 United States dollar, claim clm_DD0F42269A48 · ended · superseded by clm_3DDAC5296A48 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 30,637,000,000 United States dollar
Amgen total equity: 30,637,000,000 United States dollar, claim clm_DD2379CF3330 · ended · superseded by clm_E6437073D865 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 68,952,000,000 United States dollar
Amgen total assets: 68,952,000,000 United States dollar, claim clm_DD3641090074 · ended · superseded by clm_821821A36787 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,178,000,000 United States dollar
Amgen quarterly operating income: 1,178,000,000 United States dollar, claim clm_DD5E7F4FA2BB · ended · superseded by clm_C2025A73F657 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 1,909,000,000 United States dollar
Amgen quarterly operating income: 1,909,000,000 United States dollar, claim clm_DD998C1C3CBA · ended · superseded by clm_F7A83EC1A298 · 1 source (1 primary) · conf 0.95
unverified: One source so far: shown on the record, not asserted, until a second source or a primary one confirms it.
Amgen · website · http://www.amgen.com/
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,226,000,000 United States dollar
Amgen cash and equivalents: 3,226,000,000 United States dollar, claim clm_DE022A363AF0 · ended · superseded by clm_62DBA6442A89 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 8,658,000,000 United States dollar
Amgen total equity: 8,658,000,000 United States dollar, claim clm_DEE8552AC913 · ended · superseded by clm_598BA8F87C16 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 9,179,000,000 United States dollar
Amgen quarterly revenue: 9,179,000,000 United States dollar, claim clm_DF01174105A5 · ended · superseded by clm_56EFD8BFD444 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 19,029,000,000 United States dollar
Amgen total equity: 19,029,000,000 United States dollar, claim clm_DF80452A7941 · ended · superseded by clm_3F3775EC0C14 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · operating income · 4,312,000,000 United States dollar
Amgen operating income: 4,312,000,000 United States dollar, claim clm_E05A3DDD94DD · ended · superseded by clm_18B2DC42BBCB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 2,630,000,000 United States dollar
Amgen cash and equivalents: 2,630,000,000 United States dollar, claim clm_E0A3DD098E3C · ended · superseded by clm_950B1AD7EAC9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 929,730,507 shares
Amgen shares outstanding: 929,730,507 shares, claim clm_E1D7B78E1C33 · ended · superseded by clm_DB95FD72A669 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 40,800,000,000 United States dollar
Amgen total assets: 40,800,000,000 United States dollar, claim clm_E2811DD805A8 · ended · superseded by clm_19765841AC5F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,737,000,000 United States dollar
Amgen quarterly revenue: 5,737,000,000 United States dollar, claim clm_E2FB86DE7982 · ended · superseded by clm_569470E5C2FB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 3,308,000,000 United States dollar
Amgen quarterly revenue: 3,308,000,000 United States dollar, claim clm_E30E52778B73 · ended · superseded by clm_C0FD4A4DBDE5 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 1,653,000,000 United States dollar
Amgen quarterly net income: 1,653,000,000 United States dollar, claim clm_E3112AD96827 · ended · superseded by clm_1CD07968584F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · shares outstanding · 749,976,556 shares
Amgen shares outstanding: 749,976,556 shares, claim clm_E3B8A2E816E8 · ended · superseded by clm_7946AE508D58 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 25,778,000,000 United States dollar
Amgen total equity: 25,778,000,000 United States dollar, claim clm_E3E3E7359787 · ended · superseded by clm_771831E45D09 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 5,525,000,000 United States dollar
Amgen cash and equivalents: 5,525,000,000 United States dollar, claim clm_E548AD354AFD · ended · superseded by clm_DB87B36EEE9A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,176,000,000 United States dollar
Amgen quarterly operating income: 2,176,000,000 United States dollar, claim clm_E5A8056A8B32 · ended · superseded by clm_78C2CEAEC57D · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 6,232,000,000 United States dollar
Amgen total equity: 6,232,000,000 United States dollar, claim clm_E5BB4CC8EC5C · ended · superseded by clm_713550ADBC39 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 3,241,000,000 United States dollar
Amgen cash and equivalents: 3,241,000,000 United States dollar, claim clm_E62A544C9923 · ended · superseded by clm_8E4F00DBED65 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 31,722,000,000 United States dollar
Amgen total equity: 31,722,000,000 United States dollar, claim clm_E6437073D865 · ended · superseded by clm_4C3C0E706B52 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · shares outstanding · 540,911,490 shares
Amgen shares outstanding: 540,911,490 shares, claim clm_E74CF4B58FED · valid · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 3,216,000,000 United States dollar
Amgen quarterly net income: 3,216,000,000 United States dollar, claim clm_E7FF81925833 · ended · superseded by clm_B9855476A1FF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 90,269,000,000 United States dollar
Amgen total assets: 90,269,000,000 United States dollar, claim clm_E898DB814445 · ended · superseded by clm_8D2BB66829A3 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 67,684,000,000 United States dollar
Amgen total assets: 67,684,000,000 United States dollar, claim clm_E8B932265B26 · ended · superseded by clm_0AD0B0D546EB · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · -113,000,000 United States dollar
Amgen quarterly net income: -113,000,000 United States dollar, claim clm_E9B14F8E9889 · ended · superseded by clm_7FB87156E0B7 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 5,811,000,000 United States dollar
Amgen quarterly revenue: 5,811,000,000 United States dollar, claim clm_E9FEE791CE06 · ended · superseded by clm_3B1946434040 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,021,000,000 United States dollar
Amgen quarterly operating income: 2,021,000,000 United States dollar, claim clm_EA063E4EB60A · ended · superseded by clm_603D27640F44 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 62,948,000,000 United States dollar
Amgen total assets: 62,948,000,000 United States dollar, claim clm_EA5FD7A5E873 · ended · superseded by clm_9F85DA6C69DF · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly net income · 454,000,000 United States dollar
Amgen quarterly net income: 454,000,000 United States dollar, claim clm_EBFAA5FF45E6 · ended · superseded by clm_B28859B14384 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · revenue · 17,265,000,000 United States dollar
Amgen revenue: 17,265,000,000 United States dollar, claim clm_EC47C2B5A921 · ended · superseded by clm_3D7A43128430 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · net income · 4,090,000,000 United States dollar
Amgen net income: 4,090,000,000 United States dollar, claim clm_ED179BBDEBC9 · ended · superseded by clm_70EECF48CD48 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total equity · 23,944,000,000 United States dollar
Amgen total equity: 23,944,000,000 United States dollar, claim clm_ED303315F19F · ended · superseded by clm_8B2C132F4605 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 55,448,000,000 United States dollar
Amgen total assets: 55,448,000,000 United States dollar, claim clm_ED89BA9D10C9 · ended · superseded by clm_3519CC2C0B29 · 1 source (1 primary) · conf 0.95
valid: Two independent sources agree, or a primary source states it: the record asserts this claim, unless it is a post, is marked for review or carries a confidence below 0.5.
Amgen · SIC industry · Biological Products, (No Diagnostic Substances) (2836)
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 91,839,000,000 United States dollar
Amgen total assets: 91,839,000,000 United States dollar, claim clm_EE06CBFC7149 · ended · superseded by clm_C9D442A37C8E · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · cash and equivalents · 6,630,000,000 United States dollar
Amgen cash and equivalents: 6,630,000,000 United States dollar, claim clm_EE459468FEEE · ended · superseded by clm_A5791D18E55A · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly revenue · 10,054,000,000 United States dollar
Amgen quarterly revenue: 10,054,000,000 United States dollar, claim clm_EE4AA58E7ACE · ended · superseded by clm_985DF46177C9 · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · total assets · 49,250,000,000 United States dollar
Amgen total assets: 49,250,000,000 United States dollar, claim clm_EEC207B785D0 · ended · superseded by clm_A28B5FEC066F · 1 source (1 primary) · conf 0.95
superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
Amgen · quarterly operating income · 2,076,000,000 United States dollar
Amgen quarterly operating income: 2,076,000,000 United States dollar, claim clm_F0CFF35E1C2C · ended · superseded by clm_9938617951E0 · 1 source (1 primary) · conf 0.95

What the statuses mean